In last trading session, Allarity Therapeutics Inc (NASDAQ:ALLR) saw 25.86 million shares changing hands with its beta currently measuring 0.19. Company’s recent per share price level of $1.07 trading at $0.06 or 5.94% at ring of the bell on the day assigns it a market valuation of $4.74M. That closing price of ALLR’s stock is at a discount of -30477.57% from its 52-week high price of $327.18 and is indicating a premium of 15.89% from its 52-week low price of $0.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.8 million shares which gives us an average trading volume of 606.98K if we extend that period to 3-months.
For Allarity Therapeutics Inc (ALLR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Upright in the green during last session for gaining 5.94%, in the last five days ALLR remained trading in the red while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $1.07 price level, adding 37.79% to its value on the day. Allarity Therapeutics Inc’s shares saw a change of -8.55% in year-to-date performance and have moved -8.55% in past 5-day. Allarity Therapeutics Inc (NASDAQ:ALLR) showed a performance of -2.73% in past 30-days. Number of shares sold short was 0.18 million shares which calculate 0.3 days to cover the short interests.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Statistics highlight that Allarity Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -81.94% of value to its shares in past 6 months, showing an annual growth rate of 98.73% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.56% during past 5 years.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Insiders are in possession of 12.32% of company’s total shares while institution are holding 2.21 percent of that, with stock having share float percentage of 2.52%. Investors also watch the number of corporate investors in a company very closely, which is 2.21% institutions for Allarity Therapeutics Inc that are currently holding shares of the company.
